A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
Condition(s):Malignant Solid TumorLast Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Malignant Solid TumorLast Updated:March 5, 2024Recruiting
Condition(s):Advanced Endometrial CancerLast Updated:March 13, 2024Not yet recruiting
Condition(s):Classical Hodgkin Lymphoma; Non-Hodgkin LymphomaLast Updated:March 5, 2024Recruiting
Condition(s):Large B-cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Primary Mediastinal Large B-cell Lymphoma (PMBCL); High Grade B-cell Lymphoma (HGBCL); Grade 3B Follicular LymphomaLast Updated:May 25, 2023Approved for marketing
Condition(s):Diffuse Large B Cell LymphomaLast Updated:March 5, 2024Recruiting
Condition(s):Solid Tumor, AdultLast Updated:March 5, 2024Active, not recruiting
Condition(s):Non-CNS TumorLast Updated:February 6, 2024Recruiting
Condition(s):Solid Tumor, AdultLast Updated:March 5, 2024Recruiting
Condition(s):Breast Cancer, Breast Neoplasms; Endometrial Cancer, Endometrial Neoplasm; Ovarian Cancer, Ovarian Neoplasms; Squamous Non Small Cell Lung Cancer (NSCLC-SCC)Last Updated:March 5, 2024Recruiting
Condition(s):Non Small Cell Lung Cancer MetastaticLast Updated:March 18, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.